Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FEIBA safely and effectively. See full prescribing information for FEIBA. FEIBA® (anti-inhibitor coagulant complex) lyophilized powder for solution, for intravenous use Initial U.S. Approval: 1986
Medication labelWhy this: Advisory · dailymed-prescription
FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in hemophilia A and B patients with inhibitors for: Control and prevention of bleeding episodes Perioperative management Routine prophylaxis to prevent or reduce the frequency of bleeding episodes. FEIBA is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to coagulation factor VIII or coagulation factor IX.
- generic_name
- anti-inhibitor coagulant complex
- brand_name
- water
- product_names
- anti-inhibitor coagulant complex, water
- ndc
- 64193-424, 64193-425, 64193-426, 64764-517, 64764-519, 64764-516, 64193-424-02, 64193-324, 64193-324-01, 64764-517-20, 64193-425-02, 64193-325, 64193-325-01, 64764-519-50, 64193-426-02, 64193-326, 64193-326-01, 64764-516-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en